论文部分内容阅读
回避性/限制性摄食障碍（avoidant/restrictive food intake disorder，ARFID）是DSM-5中摄食障碍疾病，常发生于青少年儿童，也可成年起病，常表现为具有临床意义的对某些食物或食物类别摄取的回避或限制，极大影响患者身心健康。国内对于该疾病临床经验较少，国外采用营养支持、认知行为治疗以及药物治疗取得一定疗效。本文中患儿确诊为ARFID，采用体外营养、特定饮食方案，以及行为限制的前提下服用奥氮平、舍曲林、坦度螺酮取得一定的临床效果。现基于此案例展开讨论，以期为临床工作提供参考和经验。“,”Avoidant/Restrictive Food Intake Disorder(ARFID)made its diagnostic debut in DSM-5. It often occurs in adolescents and children, and can also develop in adults. It often manifests as clinically significant avoidance or restriction of intake of certain foods resulting in a great impact on the physical and mental health of patients. There is little clinical experience of this disease in China, while nutritional support, cognitive behavioral treatment and drug therapy have been used abroad to have showed some effect. In this article, the patient was diagnosed as ARFID and took olanzapine, sertraline, and tandospirone under the premise of parenteral nutrition, specific dietary regimes, and behavioral restriction to achieve certain clinical effects. The discussion based on this ARFID case may to provide clinical experience and insights for clinical practice.